U.S. markets open in 52 minutes
  • S&P Futures

    4,165.50
    +7.75 (+0.19%)
     
  • Dow Futures

    34,316.00
    +60.00 (+0.18%)
     
  • Nasdaq Futures

    13,376.00
    +72.50 (+0.54%)
     
  • Russell 2000 Futures

    2,230.90
    +5.40 (+0.24%)
     
  • Crude Oil

    66.61
    +0.34 (+0.51%)
     
  • Gold

    1,873.40
    +5.80 (+0.31%)
     
  • Silver

    28.68
    +0.41 (+1.44%)
     
  • EUR/USD

    1.2228
    +0.0071 (+0.59%)
     
  • 10-Yr Bond

    1.6400
    0.0000 (0.00%)
     
  • Vix

    19.69
    +0.88 (+4.68%)
     
  • GBP/USD

    1.4200
    +0.0063 (+0.44%)
     
  • USD/JPY

    108.9220
    -0.2780 (-0.25%)
     
  • BTC-USD

    44,754.99
    -117.94 (-0.26%)
     
  • CMC Crypto 200

    1,249.25
    +51.33 (+4.29%)
     
  • FTSE 100

    7,056.67
    +23.82 (+0.34%)
     
  • Nikkei 225

    28,406.84
    +582.01 (+2.09%)
     

Harmony Biosciences to Present at the Oppenheimer Rare and Orphan Disease Summit

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

PLYMOUTH MEETING, Pa., May 18, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced that Harmony's President and CEO, John C. Jacobs and Chief Medical Officer, Dr. Jeffrey Dayno will present a company update and host investor meetings at the Oppenheimer Rare and Orphan Disease Summit on Friday, May 21, 2021.

Harmony Biosciences logo (PRNewsfoto/Harmony Biosciences)
Harmony Biosciences logo (PRNewsfoto/Harmony Biosciences)

A webcast of the presentation will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, with a vision to provide novel treatment options for people living with rare neurological disorders who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:

Lisa Caperelli
484-539-9736
lcaperelli@harmonybiosciences.com

Harmony Biosciences Media Contact:

Nancy Leone
215-891-6046
nleone@harmonybiosciences.com

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/harmony-biosciences-to-present-at-the-oppenheimer-rare-and-orphan-disease-summit-301293012.html

SOURCE Harmony Biosciences